Prevymis Tablet, Film Coated
Product Images NDC 0006-3075

53 FDA label images from Merck Sharp & Dohme Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 53 technical images submitted to the FDA as part of the official labeling for Prevymis (NDC 0006-3075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Prevymis 01)

Chemical Structure (Prevymis 01)
Chemical structure diagram of LETERMOVIR, the active ingredient in PREVYMIS tablets. The diagram depicts the molecular arrangement and bonds of the compound.*
FDA Label Image

Figure 1 (Prevymis 02)

Figure 1 (Prevymis 02)
A cumulative incidence curve comparing Letermovir and Placebo for clinically significant CMV infection over 24 weeks post-transplant. The y-axis shows cumulative rate in percentage, and the x-axis shows weeks post-transplant from 0 to 24. Letermovir shows lower infection rates (6.8% at week 14, 18.9% at week 24) compared to Placebo (41.3% at week 14, 44.3% at week 24). Number of subjects at risk decreases over time for both groups.*
FDA Label Image

Figure 2 (Prevymis 09)

Figure 2 (Prevymis 09)
A line graph showing the cumulative rate (%) of clinically significant CMV infection with 95% confidence intervals over weeks post-transplant. It compares Letermovir (LET, 200 days) versus placebo (PBO, 100 days). The y-axis ranges from 0 to 35% and the x-axis covers weeks 14 to 48. The graph includes a table of the number of subjects at risk for each group at various time points.*
FDA Label Image

Figure 12 (Prevymis 12)

Figure 12 (Prevymis 12)
An illustration showing three food items labeled as yogurt, pudding, and applesauce. The items are depicted as a container of yogurt, a cup of pudding, and a cup of applesauce on a surface.*
FDA Label Image

Figure 13 (Prevymis 13)

Figure 13 (Prevymis 13)
An instructional illustration showing a stopwatch with a shaded segment representing 10 minutes, labeled with the text '10 minutes.' This image likely indicates a timed interval or waiting period.*
FDA Label Image

Figure 14 (Prevymis 14)

Figure 14 (Prevymis 14)
An instructional illustration showing hands under running water from a faucet, with soap lather on the hands and wrist. The image depicts proper handwashing with soap and water.*
FDA Label Image

Figure 15 (Prevymis 15)

Figure 15 (Prevymis 15)
An instructional illustration showing a person looking closely at a medication package labeled PREVYMIS with a pharmacy label. The image emphasizes reading or inspecting the pharmacy label on the medication box.*
FDA Label Image

Figure 16 (Prevymis 16)

Figure 16 (Prevymis 16)
Line drawing of a PREVYMIS tablet carton highlighting the location of the pharmacy label on the side panel of the box.*
FDA Label Image

Figure 17 (Prevymis 17)

Figure 17 (Prevymis 17)
An instructional illustration showing a measuring spoon, a bowl, a pair of scissors, a tube, and containers labeled yogurt, pudding, and apple sauce. The image likely instructs on administering or mixing a pharmaceutical product with common food items.*
FDA Label Image

Figure 18 (Prevymis 18)

Figure 18 (Prevymis 18)
An illustration showing a hand holding a spoon with medication being dispensed into a small bowl or dish held by another hand. The image depicts a step possibly related to medication preparation or administration for oral dosage.*
FDA Label Image

Figure 19 (Prevymis 19)

Figure 19 (Prevymis 19)
An instructional illustration showing a hand tapping a film-coated tablet inside a small packet to release the tablet. The image visually guides on how to dispense the PREVYMIS (letermovir) tablet from its packaging before oral administration.*
FDA Label Image

Figure 20 (Prevymis 20)

Figure 20 (Prevymis 20)
An instructional illustration showing a hand holding a small tablet bottle and a pair of scissors cutting the top of a paper or foil seal above the bottle opening, indicated by a black arrow pointing to the scissors. The image likely demonstrates how to open the medication packaging safely.*
FDA Label Image

Figure 21 (Prevymis 21)

Figure 21 (Prevymis 21)
An instructional illustration showing a hand dispensing a tablet into a small cup labeled "Tap." The image depicts the proper technique for removing or handling the PREVYMIS (letermovir) oral film-coated tablet.*
FDA Label Image

Figure 22 (Prevymis 22)

Figure 22 (Prevymis 22)
An instructional illustration showing a hand using a spoon to scoop small round beads or granules from a shallow dish or container. The hand is positioned above the container, and a dotted line emphasizes the spoon's movement or placement.*
FDA Label Image

Figure 23 (Prevymis 23)

Figure 23 (Prevymis 23)
An instructional illustration depicting a baby being fed with a spoon. The hand holding the spoon is shown placing food or medication into the baby's mouth, indicating oral administration.*
FDA Label Image

Figure 24 (Prevymis 24)

Figure 24 (Prevymis 24)
An instructional illustration showing a hand holding a tablet under running water from a faucet over a sink, demonstrating how to properly rinse or wet the tablet.*
FDA Label Image

Figure 25 (Prevymis 25)

FDA Label Image

Figure 26 (Prevymis 26)

Figure 26 (Prevymis 26)
An instructional diagram showing a medical device setup for medication administration or infusion into the lower abdominal area, with a syringe attached to tubing connecting to a device on the skin near the belly button.*
FDA Label Image

Figure 27 (Prevymis 27)

Figure 27 (Prevymis 27)
An instructional illustration showing a person receiving medication through a nasal feeding tube connected to a syringe. The diagram depicts the syringe attached to a tube inserted into the nose, indicating administration of oral medication by this route.*
FDA Label Image

Figure 28 (Prevymis 28)

Figure 28 (Prevymis 28)
An illustration of a stopwatch showing a 10-minute wait time. The clock face highlights a 10-minute segment to indicate the required waiting period.*
FDA Label Image

Figure 29 (Prevymis 29)

Figure 29 (Prevymis 29)
An instructional illustration showing a faucet running water over a hand covered with soap bubbles, demonstrating proper handwashing technique.*
FDA Label Image

Figure 30 (Prevymis 30)

Figure 30 (Prevymis 30)
An instructional illustration showing a person inspecting a PREVYMIS pharmacy label on a box. The image emphasizes verifying the label on the medication packaging before use.*
FDA Label Image

Figure 31 (Prevymis 31)

Figure 31 (Prevymis 31)
An illustration showing a PREVYMIS medication carton with an indication to locate the pharmacy label on the side panel. The carton is positioned to highlight the area where the pharmacy label is applied.*
FDA Label Image

Figure 32 (Prevymis 32)

Figure 32 (Prevymis 32)
An instructional illustration showing medical administration tools arranged on a surface, including a syringe, scissors, a tablet blister pack, a clock, a small transparent container, and a cup. The image likely demonstrates components related to drug preparation or dosing procedures.*
FDA Label Image

Figure 33 (Prevymis 33)

Figure 33 (Prevymis 33)
An instructional diagram illustrating liquid being poured from a bottle into a measuring cup partially submerged in water. The image likely demonstrates a step in measuring or preparing a liquid medication dose.*
FDA Label Image

Figure 34 (Prevymis 34)

Figure 34 (Prevymis 34)
An instructional illustration showing a hand holding a syringe being inserted into a cup, with an arrow indicating the direction of insertion. The image suggests a step in drug preparation or administration, likely related to the PREVYMIS oral tablet or liquid form.*
FDA Label Image

Figure 35 (Prevymis 35)

Figure 35 (Prevymis 35)
An instructional illustration showing a person pressing down on the plunger of a syringe to dispense liquid into a small cup. The syringe is held vertically above the cup, with a downward arrow indicating the direction of liquid flow.*
FDA Label Image

Figure 36 (Prevymis 36)

Figure 36 (Prevymis 36)
An instructional diagram illustrating how to open a medication packet by tapping the top corner to break the seal and release the contents. The image shows a hand holding the packet and tapping it with a finger for easy opening.*
FDA Label Image

Figure 37 (Prevymis 37)

Figure 37 (Prevymis 37)
An instructional illustration showing a hand holding a small tablet strip or container with multiple round tablets inside. The image highlights with an arrow where to cut the strip or container using scissors, indicating a preparation step for accessing the tablets.*
FDA Label Image

Figure 38 (Prevymis 38)

Figure 38 (Prevymis 38)
An instructional illustration showing a hand holding a tablet and tapping it against a surface above a cup filled with liquid, demonstrating how to dispense or dissolve the tablet for oral administration.*
FDA Label Image

Figure 39 (Prevymis 39)

Figure 39 (Prevymis 39)
An illustration showing a stopwatch with the first 10 minutes shaded. Text beside the stopwatch reads "Wait 10 minutes." This indicates a timed waiting instruction.*
FDA Label Image

Figure 40 (Prevymis 40)

Figure 40 (Prevymis 40)
An instructional illustration showing a syringe next to a small cup containing several round tablets or capsules, placed on a flat surface.*
FDA Label Image

Figure 41 (Prevymis 41)

Figure 41 (Prevymis 41)
An instructional illustration showing hands stirring a liquid medication in a cup with a dosing syringe. The syringe is being rotated slowly to mix the contents, demonstrating proper preparation of an oral liquid dose.*
FDA Label Image

Figure 42 (Prevymis 42)

Figure 42 (Prevymis 42)
Illustration showing a close-up of a hand pressing down and bending a film-coated tablet, possibly to split or crush it, with an arrow indicating the direction of force.*
FDA Label Image

Figure 43 (Prevymis 43)

Figure 43 (Prevymis 43)
An instructional illustration showing a person how to safely remove a needle cover by holding the syringe barrel with one hand and pulling the cover straight off with the other hand, demonstrating proper syringe needle uncapping technique.*
FDA Label Image

Figure 44 (Prevymis 44)

Figure 44 (Prevymis 44)
An instructional illustration showing the setup for an intravenous infusion, featuring a syringe connected to a flexible tube with a round port or connector. A downward arrow indicates the direction of fluid flow from the syringe into the tubing.*
FDA Label Image

Figure 45 (Prevymis 45)

Figure 45 (Prevymis 45)
An instructional diagram depicting a syringe connected by tubing to a nasal passage and mouth, likely illustrating nasal or oral administration techniques for a liquid or medication delivery via a syringe.*
FDA Label Image

Figure 46 (Prevymis 46)

Figure 46 (Prevymis 46)
An instructional illustration showing a person holding a tablet and using a syringe to withdraw liquid from a container, with an arrow indicating upward motion of the syringe plunger. The image suggests a step in medication preparation or administration.*
FDA Label Image

Figure 47 (Prevymis 47)

Figure 47 (Prevymis 47)
An instructional illustration showing two hands using a syringe to draw liquid from a small container. An arrow indicates the downward motion of the syringe plunger, suggesting extraction of the liquid into the syringe.*
FDA Label Image

Figure 48 (Prevymis 48)

Figure 48 (Prevymis 48)
An instructional illustration showing a hand pressing down on a tablet while holding a measuring cup, indicating how to crush a tablet into the cup. This likely demonstrates a preparation method related to the medication PREVYMIS (letermovir).*
FDA Label Image

Figure 49 (Prevymis 49)

Figure 49 (Prevymis 49)
An instructional illustration showing a hand holding a syringe that is being pulled upward from a container or vial, likely demonstrating the correct method to draw medication or liquid.*
FDA Label Image

Figure 50 (Prevymis 50)

Figure 50 (Prevymis 50)
An instructional illustration showing two hands holding syringes. The image depicts a motion indicating the transfer of fluid between syringes, likely as part of a reconstitution or dosage preparation process.*
FDA Label Image

Figure 51 (Prevymis 51)

Figure 51 (Prevymis 51)
An instructional illustration showing a method of administration involving a syringe connected to a tube inserted into an abdominal area. The arrow indicates fluid being pushed through the syringe into the tube, possibly demonstrating oral or enteral delivery technique.*
FDA Label Image

Figure 52 (Prevymis 52)

Figure 52 (Prevymis 52)
An instructional diagram showing the use of a syringe and a nasal delivery device, depicting the syringe connected to the nose through a tube for administering medication intranasally.*
FDA Label Image

Figure 53 (Prevymis 53)

Figure 53 (Prevymis 53)
An instructional illustration shows a hand washing a white tablet under running water from a faucet into a glass. Several tablets are soaking in a tray or container below the glass. This image likely demonstrates cleaning or preparing tablets for administration.*
FDA Label Image

Principal Display Panel (240 mg Tablet Dose Pack Carton)

Principal Display Panel (240 mg Tablet Dose Pack Carton)
PREVYMIS (letermovir) tablets 240 mg film-coated oral tablets packaging label from Merck Sharp & Dohme LLC. The label shows a 28-tablet carton with a 28-day supply, indicating 1 tablet per day. The packaging is primarily green and white with blue and green accents, featuring the proprietary name PREVYMIS prominently, along with the strength 240 mg per tablet and the generic name letermovir.*
FDA Label Image

Principal Display Panel (240 mg Tablet Blister Carton)

Principal Display Panel (240 mg Tablet Blister Carton)
PREVYMIS 240 mg (letermovir) film-coated tablets packaging label. The label displays the proprietary name PREVYMIS with the generic name letermovir, specifying 240 mg strength. It indicates the package contains 14 tablets (7 tablets per blister card, 2 blister cards), notes it is a bulk package not for dispensing and not child resistant. The labeler is Merck Sharp & Dohme LLC. The label includes tamper-evident seal placement instructions and a barcode.*
FDA Label Image

Principal Display Panel (480 mg Tablet Dose Pack Carton)

Principal Display Panel (480 mg Tablet Dose Pack Carton)
Packaging label for PREVYMIS (letermovir) tablets, 480 mg per tablet. The label indicates a 28-day supply with 28 tablets. It is a prescription oral film-coated tablet manufactured by Merck Sharp & Dohme LLC. The label includes dosage and storage instructions, the NDC code 0006-3076-02, and a small image of the pink tablet.*
FDA Label Image

Principal Display Panel (480 mg Tablet Blister Carton)

Principal Display Panel (480 mg Tablet Blister Carton)
Packaging label for Prevymis (letermovir) tablets, 480 mg oral film-coated tablets. The label shows the product name, strength, and a small pink oval tablet imprint with "595". The package contains 14 tablets (7 tablets per blister card, 2 cards). Labeler information is Merck Sharp & Dohme LLC.*
FDA Label Image

Principal Display Panel (12 mL Vial Carton)

Principal Display Panel (12 mL Vial Carton)
Packaging label for Prevymis (letermovir) Injection 240 mg/12 mL (20 mg/mL) by Merck Sharp & Dohme LLC. The label indicates the product is for intravenous infusion only, with storage instructions and dosage information. It shows that each vial contains 240 mg of letermovir in 12 mL solution, includes ingredients, and has an Rx only designation with a single-dose vial note.*
FDA Label Image

Principal Display Panel (24 mL Vial Carton)

Principal Display Panel (24 mL Vial Carton)
Carton packaging label for Prevymis (letermovir) Injection 480 mg/24 mL (20 mg/mL) by Merck Sharp & Dohme LLC. The label indicates it is for intravenous infusion only and includes storage instructions, dosage form, dilution requirements, and ingredient details. The product is a single-dose vial injection with no preservative.*
FDA Label Image

Principal Display Panel (20 mg Oral Pellets Carton)

Principal Display Panel (20 mg Oral Pellets Carton)
Packaging label for PREVYMIS (letermovir) oral pellets, 20 mg per packet. The label indicates a quantity of 30 packets in the box. It includes directions for use, storage instructions, and a barcode. The labeler is Merck Sharp & Dohme LLC. The color scheme features yellow and white backgrounds with blue accents.*
FDA Label Image

Principal Display Panel (120 mg Oral Pellets Carton)

Principal Display Panel (120 mg Oral Pellets Carton)
Packaging label for PREVYMIS (letermovir) oral pellets, 120 mg per packet, by Merck Sharp & Dohme LLC. The label shows a carton design with purple and white color scheme. It indicates 30 packets per carton and includes directions for use, storage instructions, and a barcode. The product is identified as film-coated tablets for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.